<unk>  is a photosensitizing agent that is FDA approved for the treatment of obstructive esophageal cancer, completely or partially obstructing endobronchial non-small-cell lung cancer (NSCLC), Barrett's esophagus.   Common adverse reactions include constipation, dysphagia, esophageal stricture, anemia, backache, insomnia, bronchitis, dyspnea, obstruction of bronchus, pharyngitis, stenosis of bronchus, fever, pain.
Porfimer
Epoetin alfa
Pegvaliase
Xantinol nicotinate
Diprenorfin
Memantine
Rivastigmine
Rivastigmine 